Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $750.1000 (1.36%) ($750.1000 - $750.1000) on Mon. Jun. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.55% (three month average) | RSI | 49 | Latest Price | $750.1000(1.36%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN declines -0.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(48%) XLV(44%) DIA(30%) SPLV(27%) VYM(27%) | Factors Impacting REGN price | REGN will decline at least -0.775% in a week (0% probabilities). VXX(-24%) VIXM(-20%) TBT(-5%) ACES(-5%) UUP(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.775% (StdDev 1.55%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $738.16(-1.59%) | 5 Day Moving Average | $736.89(1.79%) | 10 Day Moving Average | $737.21(1.75%) | 20 Day Moving Average | $743(0.96%) | To recent high | -9.7% | To recent low | 3.4% | Market Cap | $79.532b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |